IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for hard-to-treat blood disorder
Disease control CompletedThis study tested an experimental oral drug called PRN1008 in 86 adults with immune thrombocytopenia (ITP) whose disease had returned or did not respond to other treatments. The goal was to see if the drug could safely raise platelet counts to safer levels and reduce bleeding ris…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New hope for low platelets: drug shows promise in japanese ITP patients
Disease control CompletedThis study tested a drug called avatrombopag in 19 Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. The goal was to see if the drug could safely increase platelet counts over 26 weeks. Parti…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated May 14, 2026 12:13 UTC
-
New hope for kids with bleeding disorder: drug boosts platelets
Disease control CompletedThis study tested a medication called avatrombopag in 75 children aged 1 to 17 with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The goal was to see if the drug could safely raise platelet counts to safer levels ov…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug tested for rare blood disorder in china
Disease control CompletedThis study tested whether the drug lusutrombopag could safely raise platelet counts in Chinese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The trial involved 17 participants who hadn't responded well to standard first …
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
New registry aims to unlock secrets of rare blood disorders in youth
Knowledge-focused CompletedThis study created a registry for children and young adults with severe immune cytopenias—conditions where the immune system attacks blood cells. Researchers observed 80 participants over up to 4 years, collecting data on symptoms, treatments, and lab results. The goal was to imp…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Could cancer trick the body into attacking its own platelets?
Knowledge-focused CompletedThis study looked at 33 adults who had both cancer and a low platelet condition called immune thrombocytopenia (ITP). Researchers wanted to see if cancer cells might confuse the immune system into attacking platelets. The goal was to understand this link better, not to test a new…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC